Literature DB >> 8335011

Pertussis vaccines--1993.

H J Schmitt1, S Wagner.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 8335011     DOI： 10.1007/bf01955049

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  28 in total

Review 1.  Progress in worldwide control and elimination of disease through immunization.

Authors:  G F Hayden; P A Sato; P F Wright; R H Henderson
Journal:  J Pediatr       Date:  1989-04       Impact factor: 4.406

2.  Evaluation of Bordetella bronchiseptica vaccines in specific-pathogen-free piglets with bacterial cell surface antigens in enzyme-linked immunosorbent assay.

Authors:  P Novotny; M Kobisch; K Cownley; A P Chubb; J A Montaraz
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

3.  [Sequelae of vaccination following preventive pertussis vaccination in West Germany (1970 to 1978)].

Authors:  W Ehrengut
Journal:  Offentl Gesundheitswes       Date:  1986-03

4.  Neurological complications of pertussis inoculation.

Authors:  M Kulenkampff; J S Schwartzman; J Wilson
Journal:  Arch Dis Child       Date:  1974-01       Impact factor: 3.791

Review 5.  Pertussis immunization.

Authors:  L D Frenkel
Journal:  Pediatr Ann       Date:  1986-06       Impact factor: 1.132

6.  Identification of a 69-kilodalton nonfimbrial protein as an agglutinogen of Bordetella pertussis.

Authors:  M J Brennan; Z M Li; J L Cowell; M E Bisher; A C Steven; P Novotny; C R Manclark
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

7.  Human serum antibody responses to Bordetella pertussis infection and pertussis vaccination.

Authors:  M G Thomas; K Redhead; H P Lambert
Journal:  J Infect Dis       Date:  1989-02       Impact factor: 5.226

8.  Efficacy of an acellular pertussis vaccine in Japan.

Authors:  T Aoyama; Y Murase; T Kato; T Iwata
Journal:  J Pediatr       Date:  1985-08       Impact factor: 4.406

9.  Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children.

Authors:  C L Cody; L J Baraff; J D Cherry; S M Marcy; C R Manclark
Journal:  Pediatrics       Date:  1981-11       Impact factor: 7.124

10.  Pertussis vaccination: acellular pertussis vaccine for reinforcing and booster use--supplementary ACIP statement. Recommendations of the Immunization Practices Advisory Committee (ACIP).

Authors: 
Journal:  MMWR Recomm Rep       Date:  1992-02-07
View more
  4 in total

1.  Acellular pertussis vaccines: the final countdown.

Authors:  H J Schmitt
Journal:  Eur J Pediatr       Date:  1996-02       Impact factor: 3.183

2.  Serum antibodies to diphtheria-tetanus-pertussis vaccine components in Argentine children.

Authors:  M Pasetti; P Eriksson; F Ferrero; M Manghi
Journal:  Infection       Date:  1997 Nov-Dec       Impact factor: 3.553

Review 3.  A cellular pertussis vaccine (Infanrix-DTPa; SB-3). A review of its immunogenicity, protective efficacy and tolerability in the prevention of Bordetella pertussis infection.

Authors:  S S Patel; A J Wagstaff
Journal:  Drugs       Date:  1996-08       Impact factor: 9.546

4.  Serum antibodies to the components of diphtheria-tetanus-pertussis vaccine in Polish children related to vaccination status.

Authors:  E Torbicka; T Lagergård; B Trollfors
Journal:  Infection       Date:  1995 Jul-Aug       Impact factor: 3.553
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.